Story thread · 2 reports / 2 sources
This Pharma Stock Eyes Entry As Opioid Addiction Specialist's Profits Surge 108%
investors.com · 11d · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Opioid addiction has cast a shadow over the U.S. But this pharma stock, which targets the issue, is eyeing a fresh entry as profits soar. The post This Pharma Stock Eyes Entry As Opioid Addiction Specialist's Profits Surge 108% appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.